# LIGHTBRIDGE Corp: financial statements, quarterly

LTBR · Nasdaq · CIK 1084554 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ltbr.md) · [Financials](/companies/ltbr/financials.md) · [Filings](/companies/ltbr/filings.md) · [Insiders](/companies/ltbr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ltbr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0001477932-24-006831.md) | [0.0 d](/filings/0001477932-25-001404.md) | [0.0](/filings/0001477932-25-003550.md) | [0.0](/filings/0001477932-24-004507.md) | [0.0](/filings/0001477932-24-006831.md) | [0.0 d](/filings/0001477932-26-001076.md) | [0.0](/filings/0001477932-26-002678.md) | [0.0](/filings/0001477932-26-004756.md) | not reported | not reported | [0.0](/filings/0001477932-26-002678.md) | [0.0](/filings/0001477932-26-004756.md) |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $k | [553](/filings/0001477932-24-006831.md) | [555 d](/filings/0001477932-25-001404.md) | [1,024](/filings/0001477932-25-003550.md) | [910](/filings/0001477932-25-005731.md) | [1,299](/filings/0001477932-25-007949.md) | [1,367 d](/filings/0001477932-26-001076.md) | [1,666](/filings/0001477932-26-002678.md) | [1,640](/filings/0001477932-26-004756.md) | [2,040](/filings/0001477932-25-007949.md) | [3,865 d](/filings/0001477932-26-001076.md) | [3,348](/filings/0001477932-26-002678.md) | [3,908](/filings/0001477932-26-004756.md) |
| Operating income | $k | [(2,162)](/filings/0001477932-24-006831.md) | [(2,633) d](/filings/0001477932-25-001404.md) | [(3,182)](/filings/0001477932-25-003550.md) | [(2,702)](/filings/0001477932-25-005731.md) | [(2,975)](/filings/0001477932-25-007949.md) | [(4,201) d](/filings/0001477932-26-001076.md) | [(5,146)](/filings/0001477932-26-002678.md) | [(4,143)](/filings/0001477932-26-004756.md) | [(5,204)](/filings/0001477932-25-007949.md) | [(8,734) d](/filings/0001477932-26-001076.md) | [(7,682)](/filings/0001477932-26-002678.md) | [(7,618)](/filings/0001477932-26-004756.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [0.0](/filings/0001477932-24-006831.md) | [0.0 d](/filings/0001477932-25-001404.md) | [0.0](/filings/0001477932-25-003550.md) | [0.0](/filings/0001477932-25-005731.md) | [0.0](/filings/0001477932-25-007949.md) | [0.0 d](/filings/0001477932-26-001076.md) | [0.0](/filings/0001477932-26-002678.md) | [0.0](/filings/0001477932-26-004756.md) | [0.0](/filings/0001477932-25-007949.md) | [0.0 d](/filings/0001477932-26-001076.md) | [0.0](/filings/0001477932-26-002678.md) | [0.0](/filings/0001477932-26-004756.md) |
| Net income | $k | [(1,840)](/filings/0001477932-24-006831.md) | [(2,370) d](/filings/0001477932-25-001404.md) | [(2,820)](/filings/0001477932-25-003550.md) | [(2,375)](/filings/0001477932-25-005731.md) | [(2,656)](/filings/0001477932-25-007949.md) | [(3,937) d](/filings/0001477932-26-001076.md) | [(4,771)](/filings/0001477932-26-002678.md) | [(3,520)](/filings/0001477932-26-004756.md) | [(4,099)](/filings/0001477932-25-007949.md) | [(7,190) d](/filings/0001477932-26-001076.md) | [(6,345)](/filings/0001477932-26-002678.md) | [(5,755)](/filings/0001477932-26-004756.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001477932-23-007995.md) | not reported | [(0.21)](/filings/0001477932-25-003550.md) | [(0.17)](/filings/0001477932-25-005731.md) | [(0.19)](/filings/0001477932-25-007949.md) | not reported | [(0.24)](/filings/0001477932-26-002678.md) | [(0.16)](/filings/0001477932-26-004756.md) | [(0.16)](/filings/0001477932-25-007949.md) | not reported | [(0.20)](/filings/0001477932-26-002678.md) | [(0.18)](/filings/0001477932-26-004756.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001477932-23-007995.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [29.2](/filings/0001477932-23-007995.md) | not reported | not reported | not reported | not reported | [39.7](/filings/0001477932-26-001076.md) | not reported | not reported | not reported | [2.0](/filings/0001477932-26-004756.md) | [63.3](/filings/0001477932-26-002678.md) | [192](/filings/0001477932-26-004756.md) |
| Current assets | $m | [29.5](/filings/0001477932-23-007995.md) | [28.8](/filings/0001477932-25-001404.md) | [28.3](/filings/0001477932-24-002689.md) | [27.4](/filings/0001477932-24-004507.md) | [27.0](/filings/0001477932-24-006831.md) | [40.3](/filings/0001477932-26-001076.md) | [57.5](/filings/0001477932-25-003550.md) | [98.4](/filings/0001477932-25-005731.md) | [155](/filings/0001477932-25-007949.md) | [203](/filings/0001477932-26-004756.md) | [217](/filings/0001477932-26-002678.md) | [238](/filings/0001477932-26-004756.md) |
| Total assets | $m | [30.1](/filings/0001477932-23-007995.md) | [29.4](/filings/0001477932-25-001404.md) | [28.9](/filings/0001477932-24-002689.md) | [28.0](/filings/0001477932-24-004507.md) | [27.6](/filings/0001477932-24-006831.md) | [41.0](/filings/0001477932-26-001076.md) | [58.3](/filings/0001477932-25-003550.md) | [99.0](/filings/0001477932-25-005731.md) | [155](/filings/0001477932-25-007949.md) | [204](/filings/0001477932-26-004756.md) | [219](/filings/0001477932-26-002678.md) | [241](/filings/0001477932-26-004756.md) |
| Current liabilities | $m | [0.9](/filings/0001477932-23-007995.md) | [0.5](/filings/0001477932-25-001404.md) | [0.9](/filings/0001477932-24-002689.md) | [0.9](/filings/0001477932-24-004507.md) | [1.2](/filings/0001477932-24-006831.md) | [0.4](/filings/0001477932-26-001076.md) | [1.0](/filings/0001477932-25-003550.md) | [1.2](/filings/0001477932-25-005731.md) | [1.6](/filings/0001477932-25-007949.md) | [0.8](/filings/0001477932-26-004756.md) | [1.3](/filings/0001477932-26-002678.md) | [2.0](/filings/0001477932-26-004756.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [29.2](/filings/0001477932-24-006831.md) | [28.9](/filings/0001477932-26-001076.md) | [28.0](/filings/0001477932-25-005731.md) | [27.0](/filings/0001477932-25-007949.md) | [26.5](/filings/0001477932-25-007949.md) | [40.5](/filings/0001477932-26-004756.md) | [57.3](/filings/0001477932-26-004756.md) | [97.8](/filings/0001477932-26-004756.md) | [154](/filings/0001477932-25-007949.md) | [203](/filings/0001477932-26-004756.md) | [218](/filings/0001477932-26-004756.md) | [239](/filings/0001477932-26-004756.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,135) d](/filings/0001477932-24-006831.md) | [(2,340) d](/filings/0001477932-25-001404.md) | [(1,878)](/filings/0001477932-25-003550.md) | [(1,847) d](/filings/0001477932-25-005731.md) | [(1,944) d](/filings/0001477932-25-007949.md) | [(3,824) d](/filings/0001477932-26-001076.md) | [(3,300)](/filings/0001477932-26-002678.md) | [(2,305) d](/filings/0001477932-26-004756.md) | [(2,510) d](/filings/0001477932-25-007949.md) | [(6,166) d](/filings/0001477932-26-001076.md) | [(4,770)](/filings/0001477932-26-002678.md) | [(3,526) d](/filings/0001477932-26-004756.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2019 (2019-03-31) | Q3 FY2019 (2019-09-30) | Q1 FY2020 (2020-03-31) | Q1 FY2023 (2023-03-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2.9](/filings/0001477932-20-002678.md) | [3.2](/filings/0001477932-19-006166.md) | [3.3](/filings/0001477932-20-002678.md) | [11.7](/filings/0001477932-24-002689.md) | [13.5](/filings/0001477932-25-003550.md) | [13.9](/filings/0001477932-25-005731.md) | [14.2](/filings/0001477932-25-007949.md) | [19.5](/filings/0001477932-26-002678.md) | [22.3](/filings/0001477932-26-004756.md) | [25.6](/filings/0001477932-25-007949.md) | [32.0](/filings/0001477932-26-002678.md) | [31.9](/filings/0001477932-26-004756.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 37,458,091 at 2026-07-28, from the cover of the [10-Q filed 2026-08-06](/filings/0001477932-26-004756.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.